Correlation Between Molecular Partners and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Citius Oncology,, you can compare the effects of market volatilities on Molecular Partners and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Citius Oncology,.
Diversification Opportunities for Molecular Partners and Citius Oncology,
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Molecular and Citius is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Molecular Partners i.e., Molecular Partners and Citius Oncology, go up and down completely randomly.
Pair Corralation between Molecular Partners and Citius Oncology,
Given the investment horizon of 90 days Molecular Partners is expected to generate 2.87 times less return on investment than Citius Oncology,. But when comparing it to its historical volatility, Molecular Partners AG is 1.71 times less risky than Citius Oncology,. It trades about 0.09 of its potential returns per unit of risk. Citius Oncology, is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 106.00 in Citius Oncology, on October 20, 2024 and sell it today you would earn a total of 21.00 from holding Citius Oncology, or generate 19.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Citius Oncology,
Performance |
| Timeline |
| Molecular Partners |
| Citius Oncology, |
Molecular Partners and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Citius Oncology,
The main advantage of trading using opposite Molecular Partners and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| Citius Oncology, vs. Keurig Dr Pepper | Citius Oncology, vs. Boston Beer | Citius Oncology, vs. Ambev SA ADR | Citius Oncology, vs. Loud Beverage Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |